RCEL

AVITA MEDICAL INC

CUSIP: 05380C102

AVITA MEDICAL INC (RCEL) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.

Market Cap
-
Sector
-
Institutional Owners
0
Institutional Value
-

About

AVITA Medical, Inc. develops and commercializes regenerative medical devices for skin repair and wound management, most notably the ReCell autologous cell harvesting system that creates a spray-on suspension of a patient’s own skin cells for treatment of burns, chronic wounds and pigment disorders. The company markets its products to hospitals, burn centers and clinics worldwide and positions itself as a small-cap medtech provider offering a point-of-care alternative to traditional skin grafting and other advanced wound-care therapies.

Institutional Holders

Loading...

Source: SEC EDGAR 13F-HR filings from institutional investment managers.